Buy Generic Arimidex Online

Anastrozole –  is a non-steroidal aromatase inhibitor, can be ordering online from India at cheaper price than original.

Active substance Anastrozole
U.S. Brand Arimidex
Indian Brand Anabrex / Armotraz / Altraz
Made by Sun Pharma / Cipla / AstraZeneca
Strength 1mg
Form release blister with 5 or 10 tablets
Shipping time 7 – 21 days
Best price: 1.15 USD
through request form

DescriptionHow to use?Side EffectsLatest New'sPhoto's

Anastrozole is the generic name for the trade name drug Arimidex®. In some cases, health care professionals may use the trade name Arimidex® when referring to the generic drug name Anastrozole.

Anastrozole is used to treat early hormone receptor-positive breast cancer. It is also used for first-line treatment of hormone receptor-positive or hormone receptor-unknown advanced or metastatic (cancer that has spread) breast cancer. Anastrozole is also used to treat advanced breast cancer that has grown or spread after tamoxifen treatment. This medicine is used only in women who have already stopped menstruating (postmenopausal).

Many breast cancer tumors grow in response to estrogen. This medicine interferes with the production of estrogen in the body. As a result, the amount of estrogen that the tumor is exposed to is reduced, limiting the growth of the tumor.

 Anastrozole is in a class of medications called nonsteroidal aromatase inhibitors. It works by decreasing the amount of estrogen the body makes. This can slow or stop the growth of many types of breast cancer cells that need estrogen to grow.

The dose of Arimidex is one 1 mg tablet taken once a day. For patients with advanced breast cancer, the medication should be continued until tumor progression. Arimidex may not work as well if taken with tamoxifen or an estrogen medication.

Anastrozole comes as a tablet to take by mouth. It is usually taken once a day with or without food. Take anastrozole at around the same time every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take anastrozole exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

  • Anastrozole is a pill, taken by mouth.
  • You should take anastrozole at about the same time each day.
  • You may take anastrozole with or without food.
  • If you miss a dose of anastrozole, take it as soon as you remember unless it is almost time for the next dose. Do not take a double dose to make up a missed dose.
  • You should not stop taking anastozole without discussing with your physician, even if you feel well.

The amount of anastrozole that you will receive depends on many factors, including your general health or other health problems, and the type of cancer or condition being treated. Your doctor will determine your dose and how long you will be taking anastrozole.

Common side effects of Generic Arimidex include:

  • constipation
  • diarrhea
  • nausea
  • vomiting
  • upset stomach
  • heartburn
  • weight gain
  • joint, bone, or muscle pain
  • breast pain
  • mood changes
  • depression
  • difficulty falling asleep or staying asleep
  • nervousness
  • dizziness
  • vaginal bleeding
  • vaginal dryness or irritation
  • pain, burning, or tingling in the hands or feet
  • dry mouth
  • hair thinning

Latest Research Report

Anastrozole is a drug used to treat breast cancer in post-menopausal women. The global Anastrozole Tablets market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.

This report focuses on Anastrozole Tablets volume and value at global level, regional level and company level. From a global perspective, this report represents overall Anastrozole Tablets market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.

anastrozole therapy proved as effective

In this trial, between February 2004 and June 2010, 3,484 postmenopausal womenwith HR-positive early-stage breast cancer were randomized in 71 centers in Austria to receive either two years or five years of extended adjuvant therapy. All had undergone an initial five years of adjuvant endocrine treatment, either tamoxifen or other regimens containing aromatase inhibitors.

The trial’s primary endpoint was disease-free survival. Secondary endpoints included overall survival, contralateral breast cancer (cancer in the opposite breast), fractures, and toxicity.

Combined anastrozole and fulvestrant therapy

Study Rundown: Metastatic hormone-receptor positive breast cancer has long been associated with poor survival outcomes due to resistance to traditional therapies over time. In a breakthrough study first reported in NEJM in 2012, researchers from the S0226 trial indicated that such patients may derive some benefit from a combination therapy including anastrozole (an aromatase inhibitor) and fulvestrant (a selective estrogen receptor degrader). The initial results followed patients for a period of three years and found that the combined therapy led to increased overall survival rates and disease-free progressive survival rates when compared to a group of patients taking anastrozole alone.  This current analysis expands on those initial results, including five additional years of follow-up data. Researchers found that their overall survival and disease progression-free survival rates were still higher among patients who received the combined therapy. They also found that the safety profiles of each arm were not significantly different. This study strengthens the case for the use of combined therapy among patients with metastatic hormone-positive breast cancer.

Submit your review

Create your own review

Average rating:  
 0 reviews